UMIN ID: UMIN000052910
Registered date:27/11/2023
Investigation of the Effect of Remimazolam on Circulatory Management in Transurethral Resection of Bladder Tumor with 5-Aminolevulinic Acid
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Muscle layer non-invasive bladder cancer |
Date of first enrollment | 2023/12/31 |
Target sample size | 200 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Intraoperative minimum mean blood pressure value and duration |
---|---|
Secondary Outcome | Circulatory Agonist Usage |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1) TUR-Bt patients who used anesthesia maintenance drugs other than sevoflurane and remimazolam 2) TUR-Bt patients who did not use PDD 3) Patients who expressed their refusal to participate in this study through the information disclosure document 4) Other cases deemed inappropriate by the investigator. |
Related Information
Primary Sponsor | Chiba University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Chiba University |
Secondary ID(s) |
Contact
public contact | |
Name | Katsuhiko Ishibashi |
Address | 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba Japan 260-8677 |
Telephone | 043-222-7171 |
katsu1484@chiba-u.jp | |
Affiliation | Chiba University Hospital Anesthesiology |
scientific contact | |
Name | Katsuhiko Ishibashi |
Address | 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba Japan |
Telephone | 043-222-7171 |
katsu1484@chiba-u.jp | |
Affiliation | Chiba University Hospital Anesthesiology |